Insights

FTC Seeks Significant Penalties from Two Health Companies Alleging Misuse of Consumer Personal Information

The FTC continues its aggressive pursuit of companies it believes have mishandled consumers’ personal health information, and in particular those who have shared consumers’ information with third-party advertising platforms without consumers’ express authorization.

Compliance Congress for Specialty Products 2023 Takeaways

Choate recently sponsored the Compliance Congress for Specialty Products in Boston where attendees heard from industry experts on the latest compliance trends in the pharmaceutical industry.

Sara Frank Receives 2023 Lawyers Clearinghouse Pro Bono Excellence Award

Sara Frank is the recipient of the 2023 Lawyers Clearinghouse Pro Bono Excellence Award for her ongoing dedication as a volunteer and clinic coordinator.

FTC Finalizes Order with Genetic Testing Company 1Health.io in Privacy and Security of Genetic Information Case

The FTC recently finalized an order with genetic testing company 1Health.io (“1Health” or “Vitagene”), settling claims that it failed to live up to its privacy and security practices. This is the FTC’s first enforcement action focused on both the privacy and security of genetic information.

Sara Frank Moderating Gene Therapy Discussion at Specialty Products Compliance Congress

Sara Frank is moderating the fireside chat, “The Rise of Cell and Gene Therapy and How to Remain Compliant Amid Industry Shifts” at the Compliance Congress for Specialty Products on Wednesday, September 20th from 1:30 - 2:15 p.m.

Choate Lawyers and Practice Groups Recognized by Chambers 2023

The 2023 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 16 practice areas and 31 Choate attorneys as leading counsel in their fields, with six receiving Band 1 rankings, three receiving nationwide recognition, two global recognitions, and two senior statesmen.

Four Choate Attorneys Speak at 2023 Pharmaceutical Compliance Congress

Four of Choate's Government Enforcement attorneys will be speaking at the Pharmaceutical Compliance Congress (PCC) on April 25-27, 2023 in McLean, Virginia, including Emily Hodge, Danielle Pelot, Kristen Perriello and Sara Frank.

Jelly Bean - DOJ’s First Civil Cyber-Fraud Initiative Settlement

In this episode of our Enforcement & Investigations Podcast Series, Julia Hesse, Sara Frank and Lauren Swidler discuss the Department of Justice’s first settlement under the new Civil Cyber-Fraud Initiative against Jelly Bean Communications.

Danielle Pelot, Sara Frank and Emily Hodge to Speak at Annual Pharma Congress

Danielle Pelot, Sara Frank and Emily Hodge are participating in three panels during the Pharmaceutical and Medical Device Ethics and Compliance Congress on Monday, October 24, 2022.